I agree that this site is using cookies. You can find further informations here.
X
Hayashi, Nobuhide
78  results:
Search for persons X
?
1

Prediction of MGMT promotor methylation status in glioblast..:

Sanada, Takahiro ; Kinoshita, Manabu ; Sasaki, Takahiro...
Neuro-Oncology Advances.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

10179-NI-8 CLINICORADIOLOGICAL CHARACTERISTICS OF H3 K27-AL..:

Hayashi, Nobuhide ; Fukai, Junya ; Nakatogawa, Hirokazu...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v18-v18 , 2023
Link: https://doi.org/10.1093/..
 
?
3

10184-BT-14 CLINICAL FEATURE OF HEMISPHERIC GLIOMA WITH H3F..:

Nakatogawa, Hirokazu ; Kawaji, Hiroshi ; Hayashi, Nobuhide...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v18-v19 , 2023
Link: https://doi.org/10.1093/..
 
?
4

10025-MPC-3 DIFFERENCE AMONG GENERATIONS IN PATIENTS WITH H..:

Fukai, Junya ; Hayashi, Nobuhide ; Nakatogawa, Hirokazu...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v4-v4 , 2023
Link: https://doi.org/10.1093/..
 
?
5

10015-NI-1 PREDICTION OF MGMT PROMOTOR METHYLATION STATUS I..:

Sanada, Takahiro ; Kinoshita, Manabu ; Sasaki, Takahiro...
Neuro-Oncology Advances.  5 (2023)  Supplement_5 - p. v3-v3 , 2023
Link: https://doi.org/10.1093/..
 
?
6

MPC-8 CLINICAL CHARACTERISTICS OF H3 K27-MUTATED GLIOMAS AT..:

Hayashi, Nobuhide ; Fukai, Junya ; Nakatogawa, Hirokazu...
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii15-iii15 , 2022
Link: https://doi.org/10.1093/..
 
?
7

MPC-15 CLINICAL FEATURE OF NON-MIDLINE GLIOMA WITH H3F3A GE..:

Nakatogawa, Hirokazu ; Kawaji, Hiroshi ; Hayashi, Nobuhide...
Neuro-Oncology Advances.  4 (2022)  Supplement_3 - p. iii15-iii15 , 2022
Link: https://doi.org/10.1093/..
 
?
8

Prevalence of anti-dense fine speckled 70 antibodies in hea..:

Hayashi, Nobuhide ; Uto, Kenichi ; Imanishi, Akiko...
Medicine.  100 (2021)  9 - p. e24556 , 2021
Link: https://doi.org/10.1097/..
 
?
9

BT-1 An autopsy case of multicentric malignant glioma, H3K2..:

Hayashi, Nobuhide ; Enomoto, Hiroki ; Kubo, Kenji...
Neuro-Oncology Advances.  3 (2021)  Supplement_6 - p. vi27-vi27 , 2021
Link: https://doi.org/10.1093/..
 
?
10

MPC-02 Prognostic effects of molecular factors in elderly p..:

Fukai, Junya ; Hayashi, Nobuhide ; Arita, Hideyuki...
Neuro-Oncology Advances.  2 (2020)  Supplement_3 - p. ii11-ii12 , 2020
Link: https://doi.org/10.1093/..
 
?
11

COT-01 Experience of introducing alternating electric field..:

Hayashi, Nobuhide ; Koyama, Yoshiki ; Tsuji, Eisaku..
Neuro-Oncology Advances.  2 (2020)  Supplement_3 - p. ii21-ii21 , 2020
Link: https://doi.org/10.1093/..
 
?
12

ACT-10 TREATMENT FOR GLIOBLASTOMA RECURRED AFTER CONCOMITAN..:

Kanemura, Yonehiro ; Dehara, Makoto ; Hayashi, Nobuhide...
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii14-ii14 , 2019
Link: https://doi.org/10.1093/..
 
?
13

Radiomics and MGMT promoter methylation for prognostication..:

Sasaki, Takahiro ; Kinoshita, Manabu ; Fujita, Koji...
Scientific Reports.  9 (2019)  1 - p. , 2019
Link: https://doi.org/10.1038/..
 
?
14

COT-02 TREATMENT EXPERIENCE OF PAZOPANIB FOR A CASE OF VON-..:

Kuwata, Toshikazu ; Okada, Hideo ; Tsuji, Eisaku..
Neuro-Oncology Advances.  1 (2019)  Supplement_2 - p. ii41-ii41 , 2019
Link: https://doi.org/10.1093/..
 
?
15

Usefulness of preoperative cone beam computed tomography an..:

Hayashi, Nobuhide ; Tomura, Nagatsuki ; Okada, Hideo...
Surgical Neurology International.  10 (2019)  1 - p. 5 , 2019
Link: https://doi.org/10.4103/..
 
1-15